EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Network Pharmacology and Experimental Verification: Phellodendri Chinensis Cortex-Cnidii Fructus Herb Pair Alleviates Atopic Dermatitis by Regulating the TLR4/NF-κB Pathway

Xinyue Liu, Lele Chen, Peng Sun, Xiaolong Jiang, Pengze Li, Zichen Xu, Zhaoshuang Zhan, Jiafeng Wang

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s505248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Xinyue Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, People's Republic of China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Toll-Like Receptor 4, NF-kappa B, Network Pharmacology. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atopic Dermatitis (AD) is a common continuous inflammation dermatosis requiring efficacious therapeutic intervention. Phellodendri Chinensis Cortex-Cnidii Fructus (PC) herb pair has shown effectiveness and security in traditional Chinese medicine (TCM) clinical applications, yet its pharmacological constituents and mechanisms are not fully elucidated.

Purpose

This study used serum pharmacochemistry, network pharmacology, and validation experiments to examine the impact of PC in the treatment of AD.

Methods

Initially, ultra performance liquid chromatography-mass spectrometry (UPLC-MS) had been applied to elucidate the components of PC that were absorbed. An integrative approach combining network pharmacology and in vivo research (general index observation, skin pathological tissue staining, ELISA, immunohistochemistry, immunofluorescence, and Western blotting) was employed to validate PC's mechanism in action after 2,4-dinitrochlorobenzene (DNCB) was used to create a mouse model of AD.

Results

Fifty-three compounds and 18 serum prototype components were characterized within PC. The therapeutic efficacy of PC in AD was notably manifested in the alleviation of pruritus, improvement of skin histopathology, and reduction of cytokines involving IgE, IL-4, TNF-α and IL-6. Based on molecular docking studies, pharmacodynamic components such as phellodendrine, xanthotoxin, nomilin, and isopimpinellin strongly favored the main targets. Comprehensive investigations integrating serum pharmacochemistry, network pharmacology, and in vivo studies had revealed that PC prevented DNCB-induced AD through adjusting the TLR4/NF-κB signaling pathway.

Conclusion

The anti-AD effects of PC may be attributed to its modulation of the TLR4/NF-κB signaling pathway, reduction of NF-кB expression in the nucleusim, downregulation of inflammatory cytokine levels, provement of skin histopathological manifestations, and reduction of skin pruritus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicToll-Like Receptor 4NF-kappa BNetwork PharmacologyDrugs, Chinese HerbalPhellodendronAnimalsMiceDisease Models, AnimalMaleDinitrochlorobenzeneSignal TransductionMice, Inbred BALB C

Stichwörter der Autor:innen

Cnidii FructusPhellodendri Chinensis Cortexatopic dermatitismechanismnetwork pharmacologyserum pharmacochemistry

Substanzen

Toll-Like Receptor 4NF-kappa BDrugs, Chinese HerbalTlr4 protein, mouseDinitrochlorobenzene

Autor:innen und Institutionen

  • College of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, People's Republic of China.
  • College of Medicine, Shandong University of Traditional Chinese Medicine, Jinan, People's Republic of China.
  • College of Optometry and Ophthalmology, Shandong University of Traditional Chinese Medicine, Jinan, People's Republic of China.

Zitieren

APA

Liu, X., Chen, L., Sun, P., Jiang, X., Li, P., Xu, Z., Zhan, Z., & Wang, J. (2025). Network Pharmacology and Experimental Verification: Phellodendri Chinensis Cortex-Cnidii Fructus Herb Pair Alleviates Atopic Dermatitis by Regulating the TLR4/NF-κB Pathway. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s505248

Vancouver

Liu X, Chen L, Sun P, Jiang X, Li P, Xu Z, et al. Network Pharmacology and Experimental Verification: Phellodendri Chinensis Cortex-Cnidii Fructus Herb Pair Alleviates Atopic Dermatitis by Regulating the TLR4/NF-κB Pathway. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s505248

BibTeX
@article{Liu2025,
  author = {Liu, Xinyue and Chen, Lele and Sun, Peng and Jiang, Xiaolong and Li, Pengze and Xu, Zichen and Zhan, Zhaoshuang and Wang, Jiafeng},
  title = {Network Pharmacology and Experimental Verification: Phellodendri Chinensis Cortex-Cnidii Fructus Herb Pair Alleviates Atopic Dermatitis by Regulating the TLR4/NF-κB Pathway},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s505248}
}
Kostenlos starten →